How about you compare apples with apples? MC Company v MC company? The CPH chart doesn’t suggest a major dive does it? In fact, it’s starting to look healthier.
Anyway, was having a look at the CPH timeline, and if nothing else, CPH is one company that seems to hit its timelines. Timeline wise, there will be a lull (except for the possibility of Mernova) between now and the second half of the year:
I’d like a company update on the CanniMed products, and the recently launched anibidol products. Time for some legitimate updates from CPH to restore shareholder trust in the concept, the brands and of course, the company.
CPH Price at posting:
87.0¢ Sentiment: Hold Disclosure: Held
